Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non–Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies
Resumen
Palabras clave
Terapias adyuvantes; Cáncer de pulmón; Pronóstico
Citación recomendada
Lazar V, Girard N, Raymond E, Martini JF, Galbraith S, Raynaud J, et al. Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non–Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies. JCO Precis Oncol. 2022 Sep 15;6:e2200072.
Audiencia
Professionals
Usar este identificador para citar y/o enlazar este documento
https://hdl.handle.net/11351/8345Este elemento aparece en las siguientes colecciones
- HVH - Articles científics [2977]
- VHIO - Articles científics [865]
El ítem tiene asociados los siguientes ficheros de licencia: